Cargando…
Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379103/ https://www.ncbi.nlm.nih.gov/pubmed/35983481 http://dx.doi.org/10.2147/IJN.S385585 |
Ejemplares similares
-
Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells
por: Talaei, Fatemeh, et al.
Publicado: (2011) -
Retracted: Mannosylated Chitosan Nanoparticles for Delivery of Antisense Oligonucleotides for Macrophage Targeting
por: International, BioMed Research
Publicado: (2021) -
Retraction: Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway
Publicado: (2023) -
Thiolated Chitosan Conjugated Liposomes for Oral Delivery of Selenium Nanoparticles
por: Selmani, Atiđa, et al.
Publicado: (2022) -
Retracted: Preparation of Drug Sustained-Release Scaffold with De-Epithelized Human Amniotic Epithelial Cells and Thiolated Chitosan Nanocarriers and Its Repair Effect on Spinal Cord Injury
por: Engineering, Journal of Healthcare
Publicado: (2023)